Renegade Prepares for Belmont Stakes After Close Kentucky Derby Finish Quantinuum Sets IPO Terms Targeting Nearly 13 Billion Valuation in Quantum Computing Debut US Economy Rebounds in First Quarter of 2026 Eye On Housing Reports US 10Year Treasury Yields Could Outperform Eurozone Peers on Policy Divergence Ashok Leyland Q4 Profit Rises 14 to Rs 1291 Crore Announces Rs 25 Interim Dividend TotalEnergies Extends French Fuel Price Caps Through June Mirion Technologies MIR Q1 2026 Earnings EPS Surpasses Estimates Stock Rises DPRO Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Stock Gains on Optimism Around Operational Progress FR Q1 2026 Earnings Massive EPS Beat Drives Positive Market Reaction TENX Q1 2026 Earnings NarrowerThanExpected Loss Signals Continued Cost Discipline Wintrust Financial WTFCN Q1 2026 Earnings Solid EPS Beat Driven by Strong Net Interest Income DPRO Q1 2026 Earnings Narrowly Misses EPS Estimates No Revenue Reported Brookfield Infrastructure Corporation 7250 Subordinated Notes due 2084 BIPJ Modest Dip Amid Steady Income Appeal Enterprise Products Partners EPD Slips 3 as Energy Sector Faces Headwinds Scholar Rock SRRK Surges Nearly 7 as Biotech Momentum Builds Sunstone Hotel Investors SHO Rises Over 2 Breaking Above Key Resistance Levels Jyong Biotech Ltd MENS Gains 337 as Technical Support Holds Resistance in Focus Leonardo DRS Inc DRS Q1 2026 Earnings EPS Surges Past Estimates as Defense Demand Remains Robust TXMD Q3 2023 Earnings EPS Misses Estimates by Wide Margin Amidst Operational Challenges ATER Q3 2025 Earnings EPS Surpasses Estimates by Over 56 Stock Rises GOVX Q1 2026 Earnings Narrower Loss Surprises Shares Surge Over 32 LGN Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction April Jobs Report Preview Labor Market Cooling but Stable Economists Anticipate Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress Doximity Inc DOCS Holds Near Support After Modest Decline Blue Owl Capital OBDC Slightly Down Holds Between Defined Support and Resistance Levels LB Pharmaceuticals LBRX Holds Near Resistance as Modest Gain Signals Consolidation Biogen BIIB Posts 2 Gain as Stock Tests Resistance Near 207 LEIFRAS LFS Slips 287 as Stock Tests Key Support at 286 Genelux Corporation GNLX Gains 3 Amid Renewed Interest Key Levels to Watch Smith Nephew SNN Sheds 113 as Stock Tests Key Support Levels Columbia Sportswear COLM Rallies 38 as Shares Bounce From Key Support Level